Sunmmary Previous reports have indicated that reconstituted basement membrane (matrigel), when co-injected with either established or primary human tumour cells, can improve the growth of subcutaneous xenografts in nude mice. The human adenocarcinoma cell lines A549, SW480, and WiDr, and the human fibrosarcoma cell line HT1080scc2 exhibit varying degrees of tumourigenicity in nude mice. All these lines showed increased tumourigenicity and/or growth rate, together with a change towards a more differentiated tissue morphology, when co-injected with matrigel into nude mice. Experiments using A549 cell line have indicated that the effect of matrigel is concentration-dependent and that increased growth rate is not maintained when xenografts grown with matrigel are passaged into further mice. These results strongly suggest that increased tumour growth results from the improved growth conditions afforded by matrigel, rather than from the selection of subpopulations of the most tumourigenic cells. Increased growth of intracaecal tumours arising from the co-injection of SW480 cells with matrigel, indicate a possible use for matrigel in the development of more relevant animal models using the orthotopic site. Purified laminin significantly increased the growth of sc tumours resultant from co-injection with either WiDr or A549 cells, whereas collagen IV or laminin with entactin showed no such effect. A role for free laminin in the stimulation of cell growth in the absence of an intact basement membrane is discussed.
Many established models of anti-tumour chemotherapy are based upon the successful propagation of established cell lines of human origin as subcutaneous xenografts in athymic nude mice. Only a small minority of these cell lines however exhibit the tumourigenicity and growth rates which permit their use in such assays. The success rate of lines established in vivo from human tumours can be as low as 44% for colorectal and 10% in the case of breast (Sordat & Wang, 1984) . Consistent xenograft growth is important when attempting to minimise variation within groups both to satisfy the requirements of the experiment and also the demands of the Animals (Scientific Procedures) Act 1986 as outlined by Workman et al. (1988) . One possible way of improving such assay systems is in the use of basement membrane components.
The structure and functions of basement membrane and its constitutive proteins, together with its interaction with tumour cells, have been the subject of detailed investigations in vitro (Liotta et al., 1986; Yurchenko & Schittny, 1990) . Matrigel is a solubilised tissue basement membrane preparation extracted from the Engelbreth-Holm-Swarm murine tumour. Matrigel is composed of laminin, collagen type IV, heparin sulphate proteoglycan and entactin, along with TGF, and other growth factors which occur in the EHS tumour. Co-transplantation with matrigel has been found to enhance the growth of a range of cells in vivo including small cell lung carcinoma (SCLC), human prostatic carcinoma and human breast adenocarcinoma (Fridman et al., 1990; Pretlow et al., 1991; Noel et al., 1992) .
In this study, we present evidence of the tumour-enhancing properties of matrigel on a panel of four cell lines selected for their varied growth properties in vivo, together with observations on the concentration dependence and non-sustainability of the observed effects on subsequent passage. Of the two colon adenocarcinoma lines selected, SW480 is reported to be non-tumourigenic in nude mice (Trainer et al., 1988) and in our hands the line has a history of poor tumour growth followed by complete tumour regression after 50-60 days. WiDr colon adenocarcinoma, however, exhibits a take rate of 93-100% after about 10 days latency (West et al., 1987) .
The lung adenocarcinoma A549 was selected for its longer latency period (24-25 days), although its take rate remains high at between 90-93% (Dykes et al., 1989 (Liotta et al., 1986) . Laminin has been found to exhibit many of the biological effects of matrigel in vitro, such as promotion of tumour cell adhesion, migration, growth and invasiveness (Martin & Timpl, 1987; Barsky et al., 1984) . Entactin (Nidogen) forms a complex with laminin and is involved in the binding of laminin to collagen IV (Timpl, 1989) . Subcutaneous (sc) injection of cells with laminin or collagen type IV has been reported to have no influence on tumour growth in athymic mice, except in the case of the highly malignant B16FIO melanoma (Fridman et al., 1991) . We present a further investigation of the effects of these basement membrane components on tumour xenograft growth.
It has been shown that metastases of human colorectal carcinomas can be studied in nude mice and that its outcome depends upon the metastatic capacity of the cells and the organ environment of implantation (Giavazzi et al., 1986) . Subcutaneous tumours induced by co-injection of colon carcinoma cells with matrigel have been found to consistently lack any ability to produce metastases from this site, although recently lung colonies resulting from the i.v. injection of cells isolated from tumours induced by sc co-injection of NIH3T3 murine cells with matrigel have been observed (Fridman et al., 1992) . The use of intracaecal injection has provided a more relevant orthotopic site for studying the process of metastasis in colon cancer (Lin et al., 1991) . It has been suggested that the use of the orthotopic site for coimplantation with matrigel may result in tumours with metastases (Fridman et al., 1991 (L-15) , and all other cell lines in Dulbecco's Modified Eagle's Medium (DMEM). All media were supplemented with 10% foetal calf serum (FCS) and 1% penicillin/streptomycin solution containing 10,000 units per ml. All reagents were obtained from Gibco (Paisley, Scotland). The cells were incubated in tissue culture grade plastic flasks at 37°C. All cells except the SW480 cell line required 5% CO2 in air.
Mice
Four to 8 weeks old male athymic CD1 (nu/nu) mice were obtained from Charles River (UK) Ltd., and housed in clean conditions within positive pressure flexible film isolators.
Cell preparation After the cells had reached semi-confluence, the medium was removed and the flasks rinsed with Dulbecco's PBS lacking Ca2+ and Mg2+. The cells were incubated with a solution of 0.05%trypsin/0.02%versene to release them from the culture substratum and produce a suspension of single cells. The cells were resuspended in L-15 or DMEM, followed by a viable cell number determination by trypan-blue dye exclusion, centrifugation at +4°C, and re-suspended in cold L-15 or DMEM. A final density of 1 x 107 cells per ml was obtained by the addition of a 9:1 volume of either cold liquid matrigel (2-15mgml-'), collagen IV (3.3mgml-'), laminin (1 mg ml-') collagen + laminin (3.3 mg ml-' and 1 mg ml-') entacin-free laminin (1 mgml1'), fibrinogen (12.5mgml-') or PBS only.
Injection of cells into mice
Following preparation, 0.1 ml (1 x 106) cells were immediately injected subcutaneously (sc) with a 23-guage needle into the right subclavicular region. Generally, 5-10 mice were used for each group. Cells suspended in fibrinogen were clotted by the addition of 0.03 ml of 8 mg ml-' thrombin solution per 0.1 ml immediately prior to injection.
For intracaecal implantation, mice were anaesthetised by intraperitoneal injection of a solution of hypnorm/midazolam. A median incision was then made through the lower ventral abdominal wall over the region occupied by the caecum. The caecum was partially exteriorised and a suspension of 1 x 106 cells in 0.05 ml matrigel or PBS was injected into the caecal wall. The caecum was then returned to its normal site, the wound closed and the animal allowed to recover. After 4 weeks, an exploratory laparotomy was performed to determine interim tumour size. Autopsy and final tumour measurement was carried out at 8 weeks after implant.
Passage of xenografts
Tumours initiated from the sc injection of A549 and SW480
cell suspensions with or without matrigel were excised and 1 mm3 fragments implanted sc in nude mice using a trocar.
Tumour measurement and histology The growth of tumours was monitored twice weekly by caliper measurement of tumour length (a) and width (b). Tumour volume was estimated by using the following formula:
Tumour volume (mm3) = (a + b2)n/6
Experiments were terminated upon or prior to the mean tumour size reaching 1,000 mm3. Statistical significance was determined by Student's t test analysis. For histological examination, slices of tumour were fixed in neutral-buffered formalin prior to paraffin wax processing and the cutting of 3 gtm sections followed by staining with haematoxylin/eosin (h&e).
Results
Effect of matrigel on xenograft growth and tumourigenicity Co-injection of cells with 10 mg ml' matrigel resulted in significantly increased tumour growth rates and final tumour volumes over cells injected with medium only, in three out of the four cell lines under investigation (Figure 1 ). The growth rate of SW480 xenografts is normally very slow, the tumours beginning to regress from day 30, the majority eventually disappearing after day 50. This tendency was not observed when SW480 cells were co-injected with matrigel ( Figure Ib) . Xenograft growth of the fourth cell line, HT1080SCC2, was not significantly affected by the addition of matrigel, however, a marked increase in tumourigenicity, from 50 to 100%, was observed ( Figure Id) . There was no significant improvement in tumour size variation within groups when matrigel was used.
Effect ofpassage on xenografts grown with or without matrigel 1 mm3 fragments of A549 xenografts derived from cells inoculated with or without matrigel were washed in PBS prior to implantation into two groups of five mice. No overall difference in tumour growth rate between the two groups occurred (Figure 2 ). Similar fragments from SW480 xenografts resulting from cells co-injected with matrigel, were washed in PBS and implanted into one group of five mice. No growth of the implanted fragments occurred.
Effect of matrigel concentration on tumour growth A549 cells were co-injected with a range of matrigel concentrations from 12.1 to 1.8 mg ml-' into groups each of 5 mice over two experiments. At a concentration of 1.8 mg ml-l matrigel, there was no improvement in growth rate compared to controls. However at 3.6mg ml-' growth rate was significantly increased (P<0.01). Growth rate continued to increase with increasing matrigel concentration, up to the highest concentration attainable of 12.1 mg ml-' (Figure 3) .
Effect of matrigel components on xenograft growth, tumourigenicity and histology WiDr cells were co-injected sc into groups each of five mice with either purified laminin, laminin with entactin, matrigel, or medium only. The use of either matrigel or purified laminin resulted in a significant increase in final mean Published observations have shown that when small cell lung carcinoma cells, isolated from tumours previously induced by co-injection with matrigel, are implanted sc, tumours develop only if these cells are once more transplanted in matrigel (Fridman et al., 1991) . We report that when fragments of adenocarcinoma A549 tumours are passaged directly into nude mice, the increased growth rate of tumours derived from cells co-injected with matrigel is not maintained. This strongly suggests that the action of matrigel in tumour growth promotion may not be related to the selection of a more tumourigenic sub-population of cells, but to the creation of a more favourable environment for growth.
Examination of stained sections of WiDr and A549 tumours showed that, when grown in the presence of matrigel, the cells formed a more differentiated tissue, piling up around what appeared to be central lumen-like structures ( Figure 5) . A similar histological appearance has been reported for Walker-256 murine breast carcinosarcoma cells in tumours derived from co-injection with matrigel (Vukicevic et al., 1992) . No other morphological changes were observed, apart from those related to the increase in tumour volume over the control tumours, such as larger areas of central necrosis and increased vascularisation. Similar growth characteristics were observed with SW480 cells implanted intracaecally, where, although an improvement in tumour growth occurred after co-injection with matrigel, tumour morphology was identical to that observed in matrigelinduced sc tumours of this cell line and there were no observable micro-metastases in the liver or spleen of the host mice. We recognise that this work concerned with the effects of matrigel on tumour growth at the orthotopic site is of a preliminary nature, but we believe it is the first indication of a possible use for basement membrane products as substrates for improved orthotopic models of cancer. We have also observed that improvement in xenograft growth rate is proportional to Matrigel concentration. This confirms the finding of Fridman et al. (1991) of matrigel as low as 0.2 mg ml1' Matrigel affected tumour growth of Bl6FIO melanoma cells. In the present study, concentrations at least 15 fold higher than this were required to influence the growth of A549 tumours, a result probably relating to the different growth characteristics of these two cell lines. Growth factors present in entire matrigel may be partly responsible for these concentration-dependent mitogenic effects, however it has been observed that these effects also occur when growth factor free matrigel is used (Fridman et al., 1991) . One possible interpretation of these observations is that the multi-layered basement membrane-like structure of the gel, formed by matrigel on reconstitution at 37°C, may facilitate tumour growth by holding the cells together and allowing a greater influence on cell growth by autocrine factors. It has previously been shown that a fibrin clot can protect human tumour cells from the cytotoxic activity of natural killer (NK) cells in vitro (Gunji et al., 1988) . It is possible that matrigel may protect implanted cells from the NK cells present in athymic mice. However, co-injection of A549 cells in a fibrin-thrombin coagulate did not result in any improvement in tumour growth over cells injected with medium only. This suggests that factors other than cellular protection and initiation of aggregation are involved.
Collagen IV is important in the structural formation of basement membrane architecture. It forms a highly crosslinked scaffolding of chords, and in its intact triple-helical conformation it anchors the laminin/entactin complex, aiding cell binding (Martin & Timpl, 1987; Timpl, 1989) . We found that when A549 cells were co-injected with collagen type IV, tumour growth was not increased, suggesting that basement membrane proteins have specific roles in tumour growth.
Laminin is bound in a high affinity equimolar ratio to entactin which mediates the binding of laminin to collagen IV, whereas purified laminin shows no such binding . We have found that co-injection of purified, entactin-free, laminin significantly increases the growth of A549 and WiDr tumours, whereas laminin plus entactin has no such effect (Figure 4 ). The reasons for these results are unknown. Previous reports of co-injection with purified laminin have indicated that in most cases it does not enhance tumour growth, and it has been suggested that this is because of the highly soluble nature of laminin which renders it susceptible to degradation in vivo (Fridman et al., 1990 ).
However, purified laminin has been shown to stimulate cell proliferation in established cell lines. This activity appears to originate in domain 1 of the moleculer which is rich in EGF-like repeats, and it has been suggested that this part of the molecule may be accessible to cells only during early stages of tissue development or following injury, where the basement membrane is either not intact or has been damaged (Panayotou et al., 1989) . Thus the co-injection of cells with purified laminin may imitate this situation, causing increasing cell growth, although the situation is a complex one and other factors such as interaction with host proteins could be involved.
Our studies indicate that reconstituted basement membrane can form a basis for improved in vivo models of tumour growth using cell lines with varied growth characteristics. Assay systems could be established which utilise reduced group sizes, greater use of the orthotopic site and relatively small amounts of matrigel. We have shown that laminin plays an important part in the growth stimulatory effects of matrigel in vivo, thus confirming similar effects already reported for this protein in vitro.
